Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Cash from Operations (2022 - 2023)

Historic Cash from Operations for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to -$14.0 million.

  • Lexeo Therapeutics' Cash from Operations rose 1590.88% to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$59.5 million, marking a year-over-year change of. This contributed to the annual value of -$81.2 million for FY2024, which is 3639.74% down from last year.
  • Lexeo Therapeutics' Cash from Operations amounted to -$14.0 million in Q4 2023, which was up 1590.88% from -$13.9 million recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Cash from Operations registered a high of -$13.2 million during Q2 2023, and its lowest value of -$18.4 million during Q1 2023.